Your browser doesn't support javascript.
loading
Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison.
Halmos, Balazs; Burke, Thomas; Kalyvas, Chrysostomos; Vandormael, Kristel; Frederickson, Andrew; Piperdi, Bilal.
Afiliação
  • Halmos B; Department of Oncology, Montefiore/Albert Einstein Cancer Center, 2nd Floor, 1695 Eastchester Rd, Bronx, NY, 10461, USA. Electronic address: bahalmos@montefiore.org.
  • Burke T; Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, 07033, USA. Electronic address: thomas_burke2@merck.com.
  • Kalyvas C; Biostatistics and Research Decision Sciences, MSD Europe, Inc., Brussels, 1200, Belgium. Electronic address: chrysostomos.kalyvas@merck.com.
  • Vandormael K; Biostatistics and Research Decision Sciences, MSD Europe, Inc., Brussels, 1200, Belgium. Electronic address: kristel_vandormael@merck.com.
  • Frederickson A; precisionHEOR, Oakland, CA, 94612, USA. Electronic address: andrew.frederickson@precisionvh.com.
  • Piperdi B; Oncology Clinical Development, Merck & Co., Inc., Kenilworth, NJ, 07033, USA. Electronic address: bilal.piperdi@merck.com.
Lung Cancer ; 155: 175-182, 2021 05.
Article em En | MEDLINE | ID: mdl-33839603
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article